US Patent Issued to Marengo Therapeutics on Aug. 12 for "Antibody molecules that bind to NKP30 and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,842, issued on Aug. 12, was assigned to Marengo Therapeutics Inc. (Cambridge, Mass.).

"Antibody molecules that bind to NKP30 and uses thereof" was invented by Andreas Loew (Boston), Nidhi Malhotra (Boston), Madan Katragadda (Acton, Mass.), Brian Edward Vash (Cambridge, Mass.) and Stephanie J. Maiocco (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody molecules that specifically bind to NKp30 are disclosed. The anti-NKp30 antibody molecules can be used to treat, prevent and/or diagnose cancerous, autoimmune or infectious conditions and disorders."

The patent was filed on Aug. 13, 2021, under Application No. 17/402,320.

*For f...